Oncology

June 14th, 2017 Combining two existing prostate cancer therapies could extend the life of men with advanced, high-risk prostate cancer by 37%, found a UK clinical trial. The Guardian reports that the new findings could change how doctors first approach treatment...
Page 1 of 38123...

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.